Funding and spending
The Institute of Cancer Research, London, works closely with a number of funding organisations, including Cancer Research UK, Breast Cancer Now and the Wellcome Trust.
We also have a close partnership with The Royal Marsden NHS Foundation Trust, and together receive funding from the National Institute for Health Research for our Biomedical Research Centre.
As a member institution of the University of London, the ICR receives funding from the Office for Students (OfS) and Research England.
To safeguard our position and provide for our sustainable expansion, we aim to continually increase and diversify our sources of income.
Annual Report and Financial Statements 2024
The Institute of Cancer Research’s Annual Report and Financial Statements for the financial year ended 31 July 2024 are available to download below.
The document includes the Report of the Board of Trustees, an Independent Auditors’ report, and our statement of financial activities, balance sheet, cash flow and notes to the accounts.
The accounts are also available, on request, from 123 Old Brompton Road, London, SW7 3RP.
Income
Summary of the ICR’s income for financial year ending 31 July 2024:
Total income 2023–2024: £132.6 million
.tmb-0.png?Culture=en&sfvrsn=53036f69_1 "ICR-2024-income (1)")
This information is intended to provide a summary of the information contained in the Statement of Financial Activities of the ICR, part of the full audited annual accounts.
Expenditure
Summary of the ICR’s expenditure for financial year ending 31 July 2024:
Total expenditure 2023–2024: £152.5 million
.tmb-0.png?Culture=en&sfvrsn=cf35bbf3_1 "ICR-2024-expenditure (1)")